<DOC>
	<DOCNO>NCT00144235</DOCNO>
	<brief_summary>To assess efficacy safety Pharmaton ? PHL 00749 improve cognitive function allevi ating mental physical stress healthy male female subject lead demand lifestyle .</brief_summary>
	<brief_title>Pharmaton Upgrade Improving Mental Performance Decreasing Fatigue</brief_title>
	<detailed_description>This double-blind , placebo-controlled , randomise , parallel group trial healthy male fem ale subject regular employment . The duration dose 28 ' ( +/- 1 ) ' day assessment w ill make two visit ( visit 2 3 ) training CDR system screen visit . The subject receive one bottle 35 tablet [ either Ginseng G115 40 mg , multivitamin , mu ltimineral '+ ' Paullinia cupana extract PC102 75 mg ( Guarana ) placebo ] pharmacy vestigational site . The subject take study drug day 0 day 28 ' ( +/- 1 ) ' Subjects assign one two treatment group randomly . The allocation ratio 2:1.. Study Hypothesis : H0 : No difference exist treatment placebo group term f baseline-adjusted change Power Attention 28 day average 4 6 hour time point . H1 : A difference exist treatment placebo group term baseline-adjusted change Power Attention 28 day average 4 6 hour time point . The null alternative hypothesis secondary endpoint set accor dingly . The statistical testing carry 0.05 level signifi cance . The test perform two-tailed . Comparison ( ) : The comparator match placebo film-coated tablet without active ingredien t .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Mental Fatigue</mesh_term>
	<criteria>INCLUSION CRITERIA Healthy male female subject regular employment , age 20 50 ear . Subjects give write informed consent accordance GCP local legi slation . EXCLUSION CRITERIA Subjects present clinical depression . Subjects show evidence dementia . Clinically relevant abnormality medical history examination . Subjects participate clinical study within 3 month prior start study . History drug and/or alcohol abuse . Subjects smoke 10 cigarette per day . Subjects opinion Investigator heavy user tobacco nicotine product ( e.g . snuff , chew tobacco , nicotine patch , nicotine g um , etc. ) . Subjects history food and/or drug allergy relevant study compound . Clinically relevant deviation normal find prestudy medica l screen . Subjects unable perform cognitive test . Subjects currently take cognition enhance substance , include Ginkgo , ginseng guarana product . Any subject regularly take medication might stop time uring active dosing phase . Pregnant lactate woman female subject childbearing potential u ing adequate mean birth control ( condom , contraceptive pill , IUDs , sterili sation ) . Subjects already take multivitamin product last 2 week . Healthy subject regularly take drug act Central Nervous System ( CNS ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>